Renal clear cell carcinoma with weak to moderate NSE positivity in 30% of tumor cells.
Strong NSE immunostaining in all cells of a castration resistant prostate cancer.
Strong NSE immunostaining in all cells of a renal clear cell carcinoma.
Strong NSE immunostaining in all tumor cells of a seminoma of the testis.
Strong NSE positivity in all cells of a small cell carcinoma of the urinary bladder.